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Lay Abstract 
Autism Spectrum Disorders (Autism) are thought to be relatively common, with analyses 
estimating 1-2% in the population could meet diagnostic criteria. There is debate over 
whether the number of new cases is rising, with some suggesting an increase, whilst other 
studies finding no change. In this study we take anonymised healthcare record data from 
more than 3.6 million people in Wales to produce a national estimate of prevalence and 
incidence. We found the overall prevalence rate of autism in the population was 0.51%. The 
number of new-recorded cases of autism increased from 0.19% per 1000 person-years in 
2001 to 0.64% per 1000 person-years in 2016. The estimate of 0.51% prevalence in the 
population is lower than suggested by previous studies, potentially due to underdiagnosis or 
lack of recognition by services. From 2000-2016 the number of autism services for adults 
has increased, and autism is more widely known in society. We suggest that these extra 
services and awareness have contributed to the 3.4-fold rise in new autism diagnoses over 
the study and the >150% increase in the years 2008-2016. Our study suggests that while the 
number of people being diagnosed with autism is increasing, many are still missed by 
healthcare services.  
 
Introduction 
Autism Spectrum Disorders (hereafter Autism) are a group of complex neurodevelopmental 
disorders characterised by persistent difficulties in social interaction and communication, 
stereotypic, repetitive and restricted behaviours and interests, and difficulty coping with 
change (World Health Organisation, 2016). Autism is common, with epidemiological studies 
reporting a prevalence of 1-2% in the population, with a male to female ratio of around 3:1 
(Lai et al., 2014). Estimates of the prevalence in children suggest it has been rising since the 
1980s, with Centre for Disease Control and Prevention surveillance reports documenting an 
increase from approximately one in 150 children during 2000-2002, to approximately one in 
68 during 2010-2012 (Redfield et al., 2014). However, data from the UK General Practice 
Research Database (GPRD) suggests that autism incidence in children is static (Taylor et al., 
2013). Earlier identification and assistance for children with autism enables adaptation and 
support, and can improve social communication and reduce anxiety (Lai et al., 2014). As 
autism spectrum conditions are lifelong neurodevelopmental conditions, underpinned by 
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atypical neural system development, it is anticipated that increases in childhood diagnosis 
will correspond to increased rates amongst adults, though this has not yet been 
substantiated (Lai et al., 2014). The aims of this study were to determine the prevalence and 
incidence of autism within the Welsh population. Validation of incidence data on a 
population level offers the opportunity to inform future healthcare policy and provision, 
leading to improvements in quality of life for adults with autism.   
Methodology 
Data sources, Population and Settings  
This was a retrospective population based electronic cohort study. Data was sourced from 
the Secure Anonymised Information Linkage (SAIL) Databank (www.saildatabank.com) 
(Lyons et al., 2009). SAIL is a data repository of anonymised person based linkable data from 
healthcare and public settings. Data access was approved by the SAIL independent 
Information Governance Review Panel in 2018 (application 0843). The policies, permissions, 
processes, structures and controls applied to manage the SAIL databank are described 
elsewhere (John et al., 2018).  
This study used the Welsh Longitudinal General Practice dataset (WLGP) and PEDW (Patient 
Episode Database for Wales) for extracting relevant diagnostic data, and the Welsh 
Demographic Service Dataset (WDSD), which includes anonymised demographics, 
geographic index (LSOA = Lower Layer Super Output Area index 2011) and deprivation data 
(Welsh Index of Multiple Deprivation quintile 2011). The WDSD is an administrative register 
of all individuals in Wales to use NHS services, including anonymised demographics and 
general practice registration.  
3.63 million individuals from the Welsh population over the period 2000-2016 were 
included in the study. The PEDW dataset comprises hospital admissions (inpatient and day 
case) clinical information for all NHS Wales hospitals. At the time of the analysis 333 (of 432, 
77%) general practices in Wales were supplying their data to SAIL for the WLGP dataset, 
covering 79% of the population. Individuals with autism were identified in the WLGP and 
PEDW datasets using ICD (International Classification of Diseases) version 10 codes and 
Read Codes v2. This methodology has been validated in previous studies of other psychiatric 
disorders (Lloyd et al., 2015). The autism cohort utilised ICD-10 codes: F840, F841, F845, 
plus the ‘legacy’ codes F84.., F842, F843, F844, F848, and F849. The Read v2 Codes used 
were: 1J9.., E140., E1400, E1401, E140z, Eu840, Eu841, Eu845, E141., Eu84., Eu842, Eu843, 
Eu844, Eu846, Eu84y, and Eu84z. 
Statistical Analysis 
Data in the SAIL databank were interrogated using structured query language (SQL DB2). 
Analysis of outputs were processed utilising IBM SPSS Statistics 23 for Window (IBM Corp. 
Released, 2015). For analysis of incidence and prevalence, the denominator included all indi-
viduals alive and living in Wales and registered with a GP providing data to SAIL between 1st 
of January 2000 and 31st of December 2016. Age during this period or at time of diagnosis 
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was not relevant. Prevalence of autism and annual rates of first ever incident recorded au-
tism were calculated for the whole 16-year period or until death, whichever was earlier. A 
new incident episode was defined as an entry in the records with no previous entry of that 
problem ever recorded and with at least six months’ worth of WLGP data prior to that diag-
nosis. Annual first ever incident rates were calculated per person years at risk. Person-time 
at risk was calculated using the start of each year (1st January) or start of registration (plus 
six months), whichever later. End date was earliest of: date of leaving practice supplying 
SAIL, date of death, or end of year (31st December).   
Results 
Autism Incidence and Prevalence 
The yearly incidence for new recording in health record of autism diagnosis incorporating all 
3,632,078 SAIL participants increased over the study period (2001-2016), from 0.19% per 
1000 person-years in 2001, up to a maximum of 0.64% per 1000 person-years in 2016 
(Figure 1), a 3.4-fold increase. This change comprised an increase in incidence in both male 
and female individuals, from 0.32% and 0.06% per 1000 person-years at risk up to 0.95% 
and 0.35% per 1000 person-years respectively for 2016 (Figure 1).  
Figure 1: Incidence and Prevalence of Autism in the SAIL dataset over assessed years (2001-2016) 
 
 
Incidence and Prevalence calculated utilising person years at risk (see Methodology). Cumulative incorporates 
male and female data. 
The prevalence of autism also increased across the assessed period, from 0.19 per 1000 
people in 2001 to 5.07 per 1000 people in 2016 (Figure 1). This cumulative figure 
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prevalence rose from 0.32 per 1000 people in 2001 to 7.99 per 1000 people in 2016. Female 
prevalence rose from 0.06 per 1000 people in 2001 to 2.15 per 1000 people in 2016.  
Discussion 
In this large population-based electronic-cohort study we draw on anonymised data from 
General Practice and Hospital Patient Encounters for over 3.6 million individuals 
representative of the population of Wales to produce national estimates of autism 
prevalence and incidence. We found a prevalence of autism of 0.51% in 2016, and a 3.4-fold 
increase in autism incidence over the study period from 0.19% per 1000 person-years in 
2001, up to a maximum of 0.64% per 1000 person-years in 2016. 
Estimates point to a prevalence of autism in the general population around 1-2% (Brugha et 
al., 2011; Lai et al., 2014; Lord et al., 2020; Redfield et al., 2014; Russell et al., 2015; 
Simonoff et al., 2008; Taylor et al., 2013). Prior studies of autism prevalence have examined 
a number of birth cohorts, CDC surveillance data on children’s health records in the US, and 
the General Practice Research Database (GPRD) for general practice health records of 
children in the UK (Elsabbagh et al., 2012; Redfield et al., 2014; Russell et al., 2015; Taylor et 
al., 2013). Brugha et al were reportedly the first to ascertain data for adults, finding a 
prevalence of 0.98-1.1% using a national stratified survey methodology (Brugha et al., 2011, 
2016). Our prevalence estimate of 0.51% is lower than these epidemiological studies, which 
may be due to methodological differences reflecting the under-identification and reporting 
of autism in healthcare records.  
We demonstrate a marked increase in incidence of autism diagnosis, particularly in the 
eight-year period from 2008-2016. During this time new recorded diagnoses increased by 
>150%. Despite this, the absolute incidence rate remains low. Multiple groups have 
reported that rates of autism diagnosis are increasing over time, though with a more recent 
plateau (Lai et al., 2014; Russell et al., 2015). Comparative data from the General Practice 
Research Database (GPRD) has demonstrated that the incidence rate amongst children 2-8 
years during an overlapping time period (2001-2010) remained static (Taylor et al., 2013). 
We, like others, would suggest that this increase is due to recognition, increased societal 
awareness, changes in practice and improved availability of diagnostic services particularly 
for adults with autism (Lai et al., 2014; Lord et al., 2020; Russell et al., 2015).  
This study utilised the SAIL Database, a nationally-representative, high quality anonymised 
e-cohort of >3.6 million individuals (Lyons et al., 2009). We reviewed General Practice and 
Hospital Encounter datasets, comprising ICD-10 and Read v2 Codes for diagnoses under 
analysis. As an e-cohort study, exposure and outcome classification errors cannot be 
excluded as we are unable to verify the diagnoses. Electronic records of General Practice 
data prior to 2000 are sparsely held in the SAIL Databank, and therefore prevalent cases 
prior to 2000 may be missing from this estimate. This explains the dramatic increase from 
very low baseline of our reported prevalence. We rely upon accurate documentation by 
healthcare staff, and just 21.67% of our sample had an autism diagnosis in both datasets. It 
is likely our study misses individuals with autism in the community who have not come into 
contact with their GP or Hospital services resulting in their diagnosis not being on record. 
 . CC-BY 4.0 International licenseIt is made available under a 
perpetuity. 
 is the author/funder, who has granted medRxiv a license to display the preprint in(which was not certified by peer review)preprint 
The copyright holder for thisthis version posted February 19, 2021. ; https://doi.org/10.1101/2021.02.17.21250756doi: medRxiv preprint 
Our study is therefore likely to be an underestimation. Diagnostic overshadowing, the 
practice of one diagnosis taking primacy and leading to underdiagnosis of co-occurring 
conditions, is also recognised to be a problem within autism (Brugha, 2018). Both of these 
limitations may compound to generate errors in our estimates and contribute to lower 
figures, although our large sample size and replication of comparable results would suggest 
these errors are minimal. We have attempted to compensate through use of both primary 
and secondary care data, and these limitations are common to e-cohort and record linkage 
studies which depend upon individuals’ attendance, recognition and recording to be 
accurate.  
In conclusion, in our national population sample we found a marked rise in incidence over 
the study period to 2016. This is consistent with improved societal recognition and access to 
diagnostic services resulting in greater rates of diagnosis; incident cases not picked up in 
childhood being diagnosed as adults. Despite this we found lower prevalence rates than 
demonstrated in previous studies, suggesting that a large proportion of those adults with 
autism are not recognised by the healthcare system. 
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